• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.

作者信息

Steeg P S, Clare S E, Lawrence J A, Zhou Q

机构信息

Women's Cancers Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Am J Pathol. 1996 Sep;149(3):733-8.

PMID:8780376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1865140/
Abstract
摘要

相似文献

1
Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.人乳腺癌前病变和原位癌的分子分析
Am J Pathol. 1996 Sep;149(3):733-8.
2
Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.微腺性腺病（MGA）进展为浸润性癌的分子证据。
Am J Surg Pathol. 2009 Apr;33(4):496-504. doi: 10.1097/PAS.0b013e31818af361.
3
Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.原位和浸润性乳腺癌中人类11号染色体的微卫星改变：显微切割微卫星分析及其与p53、雌激素受体（ER）和孕激素受体（PR）蛋白免疫反应性的相关性
J Surg Oncol. 2000 Jun;74(2):100-7. doi: 10.1002/1096-9098(200006)74:2<100::AID-JSO5>3.0.CO;2-O.
4
Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.乳腺导管原位癌：组织学分类与生物学标志物之间的相关性
Mod Pathol. 1997 Nov;10(11):1088-92.
5
The p53 tumor suppressor gene in ductal carcinoma in situ of the breast.乳腺导管原位癌中的p53肿瘤抑制基因。
Am J Pathol. 2000 Jan;156(1):5-6. doi: 10.1016/S0002-9440(10)64698-6.
6
[Transplantation of human primary in-situ and invasive breast carcinoma in nude mice].
Zhonghua Zhong Liu Za Zhi. 1996 Sep;18(5):321-3.
7
Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.细胞周期蛋白依赖性激酶抑制剂（p27和p21）在口腔鳞状细胞肿瘤发生中的差异表达及其与p53和Ki-67的关系。
Int J Oncol. 2003 Feb;22(2):409-14.
8
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.微小腺腺病及向原位癌和浸润癌转变的临床、组织病理学及免疫组化特征。
Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.
9
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.
10
Prostatic intraepithelial neoplasia. Relationship to adenocarcinoma of prostate.前列腺上皮内瘤变。与前列腺腺癌的关系。
Pathol Annu. 1994;29 ( Pt 2):1-30.

引用本文的文献

1
Lactation-induced WAP-SV40 Tag transgene expression in C57BL/6J mice leads to mammary carcinoma.哺乳期诱导的WAP-SV40 Tag转基因在C57BL/6J小鼠中的表达会导致乳腺癌。
Transgenic Res. 1998 Jul;7(4):253-63. doi: 10.1023/a:1008865911660.
2
Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.乳腺增生中的杂合性缺失和微卫星不稳定性。这些基因改变与后续恶性肿瘤之间不存在必然关联。
Am J Pathol. 1997 Jun;150(6):1925-32.

本文引用的文献

1
Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.与组织学类型和分级相关的乳腺导管内肿瘤的基因改变模式。
Clin Cancer Res. 1995 Mar;1(3):261-7.
2
Antigen-presenting cell engineering. The molecular toolbox.抗原呈递细胞工程。分子工具箱。
Am J Pathol. 1996 Jan;148(1):1-16.
3
The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.
Breast Cancer Res Treat. 1995;36(2):119-26. doi: 10.1007/BF00666034.
4
Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.乳腺导管原位癌中17号染色体上的等位基因缺失。
Cancer Res. 1993 Jul 1;53(13):2947-9.
5
Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.乳腺导管原位癌中雌激素受体的表达：与DNA流式细胞术分析及c-erbB-2癌蛋白表达的关系。
Br J Cancer. 1993 Jul;68(1):156-61. doi: 10.1038/bjc.1993.305.
6
p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein.乳腺导管原位癌中p53蛋白表达：与雌激素受体及c-erbB-2蛋白免疫组化表达的关系
Hum Pathol. 1993 May;24(5):463-8. doi: 10.1016/0046-8177(93)90157-c.
7
p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.p53突变局限于乳腺粉刺型导管原位癌。免疫组织化学和测序数据。
Lab Invest. 1994 Jul;71(1):67-72.
8
Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team.导管原位癌（DCIS）的乳腺钼靶特征与C-erbB-2癌基因表达之间的相关性。诺丁汉乳腺团队。
Clin Radiol. 1994 Aug;49(8):559-62. doi: 10.1016/s0009-9260(05)82937-x.
9
Identification of genes expressed in premalignant breast disease by microscopy-directed cloning.通过显微镜引导克隆鉴定癌前乳腺疾病中表达的基因。
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9257-61. doi: 10.1073/pnas.91.20.9257.
10
c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.c-erbB-2/neu过表达通过诱导转移相关特性增强人肺癌细胞的转移潜能。
Cancer Res. 1994 Jun 15;54(12):3260-6.